Comparison of antitumor activities in tumor xenograft treatment

Contemporary Clinical Trials

Volumn 28, Issue 2, 2007, Pages 115-119

  Liang, Hua ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Bootstrap; Comparison curve; Synergy; Tumor xenograft models

Indexed keywords

ANTINEOPLASTIC AGENT; IRINOTECAN; IROFULVEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; MOUSE; MULTIPLE CYCLE TREATMENT; NONHUMAN; TREATMENT OUTCOME; TUMOR MODEL; TUMOR VOLUME; TUMOR XENOGRAFT;

ALGORITHMS; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CAMPTOTHECIN; DISEASE MODELS, ANIMAL; HUMANS; MICE; SESQUITERPENES; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 33845592772     PISSN: 15517144     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cct.2006.05.001     Document Type: Article

References (14)

1. Britten C.D., Hilsenbeck S.G., Eckhardt S.G., et al. Enhanced Antitumor Activity of 6-Hydroxymethylacylfulvene in Combination with Irinotecan and 5-Fluorouracil in the HT29 Human Colon Tumor Xenograft Model. Cancer Res 59 (1999) 1049-1053
2. McCreery H., Rowinsky E.K., Tolcher A., et al. Phase I trial of irofulven and CPT-11 in patients with advanced cancers. 2002 ASCO Annual Meeting.
3. Kelner M.J., McMorris T.C., Estes L., et al. Anti-leukemic action of the novel agent MGI 114 (HMAF) and synergistic action with topotecan. Leukemia 14 (2000) 136-141
4. Woo M.H., Peterson J.K., Billups C., et al. Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models. Cancer Chemother Pharmacol 55 (2005) 411-419
5. Houghton P.J., Cheshire P.J., Hallman J.D., et al. Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors. Cancer Chemother Pharmacol 36 (1995) 393-403
6. Hall P., and Hart J.D. Bootstrap test for difference between means in nonparametric regression. J Am Stat Assoc 85 (1990) 1039-1049
7. Young S.G., and Bowman A.W. Non-parametric analysis of covariance. Biometrics 51 (1995) 920-931
8. Härdle W., and Mammen E. Comparing non-parametric versus parametric regression fits. Ann Stat 21 (1993) 1926-1947
9. Härdle W., and Marron S. Semiparametric comparison of regression curves. Ann Stat 18 (1990) 63-89
10. Cox D.R., Koh E., Wahba G., and Yandell B.S. Testing the (parametric) null model hypothesis in (semi-parametric) partial and generalized spline model. Ann Stat 16 (1988) 113-119
11. Eubank R.L., and Hart J.D. Commonality of Cusum, von Neumann and smoothing-based goodness-of-fit tests. Biometrika 80 (1993) 89-98
12. Liang H. Comparison of curves based on Cramér-von Mises statistic. Comput Stat Data Anal 45 (2004) 805-812
13. Efron B., and Gong G. A leisurely look at the bootstrap, the jackknife and cross-validation. Am Stat 37 (1983) 36-48
14. Liang H., and Sha N.J. Modeling antitumor activity by using a nonlinear mixed-effects models. Math Biosci 189 (2004) 61-73